Key result
Stanozolol accelerates atherosclerosis progression in mice by activating CSK- and FBLN1-mediated inflammatory pathways.
Answers are grounded in this paper and cite their sources.
Stanozolol accelerates atherosclerosis progression in ApoE-/- mice by activating inflammatory responses and disrupting vascular homeostasis, mediated by CSK and FBLN1.
BACKGROUND Stanozolol, a synthetic anabolic androgenic steroid (AAS) widely abused to enhance performance, has poorly defined toxicological mechanisms in atherosclerosis (AS). METHODS An AS model was established in ApoE-/- mice, followed by a 12-week stanozolol intervention. Effects on lipid metabolism, systemic inflammation, and plaque formation were assessed. Potential targets were predicted via database integration. Transcriptomic analyses included differential expression, WGCNA, GSEA, CIBERSORT, and single-cell RNA-seq. Core toxic targets were identified using LASSO, SVM-RFE, and random forest. Validation was performed by qRT-PCR, Western blotting, and immunofluorescence. Molecular docking and 100-ns MD simulations were conducted to assess binding affinity and stability. RESULTS Stanozolol significantly aggravated AS progression, marked by increased lipid deposition, vascular remodeling, dyslipidemia, and systemic inflammation. Integration of multi-omics and machine learning identified three key targets-CSK, FBLN1, and BCHE-With stable binding to stanozolol. Functional assays showed CSK upregulation in macrophages and FBLN1 downregulation in vascular smooth muscle cells. CONCLUSION Stanozolol accelerates atherosclerosis by activating inflammatory responses and disrupting vascular homeostasis. CSK and FBLN1 are core toxic mediators and potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied Atherosclerosis. Stanozolol was evaluated on Atherosclerosis progression (lipid deposition, vascular remodeling, dyslipidemia, and systemic inflammation). Stanozolol significantly aggravated atherosclerosis progression in ApoE-/- mice by activating inflammatory responses, with CSK and FBLN1 identified as core toxic mediators.
Synapse has enriched 10 related papers. Consider them for comparative context: